Literature DB >> 34608273

lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.

Hai-Ting Liu1,2, Yong-Xin Zou1, Wen-Jie Zhu1, Guo-Hao Zhang1, Ran-Ran Ma1, Xiang-Yu Guo1, Peng Gao3,4.   

Abstract

Long noncoding RNAs (lncRNAs) are dysregulated in different cancer types, and thus have emerged as important regulators of the initiation and progression of human cancers. However, the biological functions and the underlying mechanisms responsible for their functions in gastric cancer (GC) remain poorly understood. Here, by lncRNA microarray, we identified 1414 differentially expressed lncRNAs, among which THAP7-AS1 was significantly upregulated in GC tissues compared with non-tumorous gastric tissues. High expression of THAP7-AS1 was correlated with positive lymph node metastasis and poorer prognosis. SP1, a transcription factor, could bind directly to the THAP7-AS1 promoter region and activate its transcription. Moreover, the m6A modification of THAP7-AS1 by METTL3 enhanced its expression depending on the "reader" protein IGF2BP1-dependent pathway. THAP7-AS1 promoted GC cell progression. Mechanistically, THAP7-AS1 interacted with the 1-50 Amino Acid Region (nuclear localization signal) of CUL4B through its 1-442 nt Sequence, and it promoted interaction between nuclear localization signal (NLS) and importin α1, and improved the CUL4B protein entry into the nucleus, repressing miR-22-3p and miR-320a expression by CUL4B-catalyzed H2AK119ub1 and the EZH2-mediated H3K27me3, subsequently activating PI3K/AKT signaling pathway to promote GC progression. Moreover, LV-sh-THAP7-AS1 treatment could suppress GC growth, invasion and metastasis, indicating that THAP7-AS1 may act as a promising molecular target for GC therapies. Taken together, our results show that THAP7-AS1, transcriptionally activated by SP1 and then modified by METTL3-mediated m6A, exerts oncogenic functions, by promoting interaction between NLS and importin α1 and then improving the CUL4B protein entry into the nucleus to repress the transcription of miR-22-3p and miR-320a.
© 2021. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34608273      PMCID: PMC8901790          DOI: 10.1038/s41418-021-00879-9

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  1 in total

1.  EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.

Authors:  Hai-Ting Liu; Sen Liu; Lei Liu; Ran-Ran Ma; Peng Gao
Journal:  Cancer Res       Date:  2018-09-05       Impact factor: 12.701

  1 in total
  13 in total

Review 1.  The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.

Authors:  Lin Luo; Yingwei Zhen; Dazhao Peng; Cheng Wei; Xiaoyang Zhang; Xianzhi Liu; Lei Han; Zhenyu Zhang
Journal:  Cell Death Discov       Date:  2022-07-18

Review 2.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

3.  METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer.

Authors:  Nuofan Wang; Xinying Huo; Baoguo Zhang; Xiaoxiang Chen; Shuli Zhao; Xuesong Shi; Hao Xu; Xiaowei Wei
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

Review 4.  N6-Methyladenosine Modifications in the Female Reproductive System: Roles in Gonad Development and Diseases.

Authors:  Hongbei Mu; Huiying Li; Yu Liu; Xiaofei Wang; Qiaojuan Mei; Wenpei Xiang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 5.  LINC00520: A Potential Diagnostic and Prognostic Biomarker in Cancer.

Authors:  Qiudan Zhang; Jinze Shen; Yuchen Wu; Wenjing Ruan; Feng Zhu; Shiwei Duan
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

6.  5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer.

Authors:  Zhuoyuan Li; Siyu Wang; Yuxian Chen; Yaozhou Huang; Tianping Li
Journal:  Dis Markers       Date:  2022-03-04       Impact factor: 3.434

Review 7.  The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer.

Authors:  Chao-Yue Sun; Di Cao; Bin-Bin Du; Cun-Wu Chen; Dong Liu
Journal:  Int J Biol Sci       Date:  2022-03-28       Impact factor: 10.750

8.  Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.

Authors:  Dongliang Li; Zejun Fu; Chaoqun Dong; Yongming Song
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

9.  Buffalo long non-coding RNA gene11007 promotes myoblasts proliferation.

Authors:  Ning Zhang; Gaoxiao Xu; Ping Sun; Shuzhe Wang; Yunchang Zhu; Saixing Duan; Mingsheng Jiang; Hui Li; Xuefeng Wei; Yun Ma
Journal:  Front Vet Sci       Date:  2022-08-05

10.  Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.

Authors:  Yiyang Hu; Chunli Gong; Zhibin Li; Jiao Liu; Yang Chen; Yu Huang; Qiang Luo; Sumin Wang; Yu Hou; Shiming Yang; Yufeng Xiao
Journal:  Mol Cancer       Date:  2022-02-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.